Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Injectable GHK-Cu is classified Category 2 by the FDA, restricting it from 503A pharmacy compounding
With the help of stacking peptides, your doctor can create a comprehensive approach to health optimization
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in San Jose, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year
2021;22(2):e13137
Table 2 Supplement dose ranges and effects
Injectable GLP-1s studied for weight loss (like Wegovy and Zepbound) have produced substantial average weight loss in trials when combined with diet and exercise
